Radiotherapy for lung cancer in the elderly

Neil Bayman; Nooreen Alam; Corinne Faivre-Finn

doi:10.1016/j.lungcan.2009.12.004

Radiotherapy for lung cancer in the elderly

Neil Bayman, Nooreen Alam, Corinne Faivre-Finn

Research output: Contribution to journal › Article › peer-review

Abstract

Mortality from lung cancer is increasing in patients ≥ 70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment. © 2009 Elsevier Ireland Ltd.

Original language	English
Pages (from-to)	129-136
Number of pages	7
Journal	Lung Cancer
Volume	68
Issue number	2
DOIs	https://doi.org/10.1016/j.lungcan.2009.12.004
Publication status	Published - May 2010

Keywords

Comprehensive geriatric assessment
Elderly
Non-small-cell lung cancer
Radiotherapy
Small-cell lung cancer
Toxicity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.lungcan.2009.12.004

Cite this

@article{8ca0702a01c743fcb9975ca00a3387da,

title = "Radiotherapy for lung cancer in the elderly",

abstract = "Mortality from lung cancer is increasing in patients ≥ 70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment. {\textcopyright} 2009 Elsevier Ireland Ltd.",

keywords = "Comprehensive geriatric assessment, Elderly, Non-small-cell lung cancer, Radiotherapy, Small-cell lung cancer, Toxicity",

author = "Neil Bayman and Nooreen Alam and Corinne Faivre-Finn",

year = "2010",

month = may,

doi = "10.1016/j.lungcan.2009.12.004",

language = "English",

volume = "68",

pages = "129--136",

journal = "Lung Cancer",

issn = "0169-5002",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - Radiotherapy for lung cancer in the elderly

AU - Bayman, Neil

AU - Alam, Nooreen

AU - Faivre-Finn, Corinne

PY - 2010/5

Y1 - 2010/5

N2 - Mortality from lung cancer is increasing in patients ≥ 70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment. © 2009 Elsevier Ireland Ltd.

AB - Mortality from lung cancer is increasing in patients ≥ 70 years. Radiotherapy has an important role in the treatment of lung cancer for this group. Despite this, there have been few elderly specific trials of radiotherapy in lung cancer and current treatment is often based on evidence extrapolated from studies treating younger patients. This review of the literature examines the impact of radiotherapy for the radical and palliative treatment of non-small-cell and small-cell lung cancer, on survival, treatment-related toxicity and quality of life in the elderly. We also comment on the need for validated, practical geriatric screening and assessment tools to help predict toxicity to treatment. © 2009 Elsevier Ireland Ltd.

KW - Comprehensive geriatric assessment

KW - Elderly

KW - Non-small-cell lung cancer

KW - Radiotherapy

KW - Small-cell lung cancer

KW - Toxicity

U2 - 10.1016/j.lungcan.2009.12.004

DO - 10.1016/j.lungcan.2009.12.004

M3 - Article

C2 - 20079949

SN - 0169-5002

VL - 68

SP - 129

EP - 136

JO - Lung Cancer

JF - Lung Cancer

IS - 2

ER -

Radiotherapy for lung cancer in the elderly

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this